Meeting
2024 ASCO Annual Meeting
Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer.
Presenter
Caroline Ford, PhD
UNSW
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 5547)
DOI
10.1200/JCO.2024.42.16_suppl.5547
Abstract #
5547
Poster Bd #
418
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Annual Meeting
Timing of Debulking Surgery in Advanced Endometrial and Ovarian Cancers
Speaker: Amer Karam, MD
Videos & Slides
2024 ASCO Annual Meeting
On-treatment (tx) dynamic circulating tumor DNA changes (∆ctDNA) associated with progression-free survival (PFS) and overall survival (OS) of patients (pts) with HR+/HER2− advanced breast cancer (ABC) in MONALEESA-3 (ML-3).
Speaker: Stephen K. L. Chia, MD, FRCPC
Videos & Slides
2024 ASCO Annual Meeting
Threading the Needle in the Haystack: ctDNA Applications in Early and Advanced Breast Cancer
Speaker: Daniel G. Stover, MD, FASCO
Videos & Slides
2024 ASCO Annual Meeting
Discriminating subtypes in advanced breast cancer with ctDNA methylation profiling.
Speaker: Ros Cutts, PhD